Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

How climate change will hit animal health
tick
"Climate change... may increase the presence of vectors such as ticks, mosquitoes and fleas".
IFAH-Europe warns of the need for innovative medicines

Climate change may lead to Europe seeing more new diseases in animals and humans, IFAH-Europe is warning as it calls for more innovation in veterinary medicines.

"We are seeing incidences of animal disease in Europe that were not previously reported," said Roxanne Feller, the organisation's secretary general.

Examples include the introduction of Schmallenberg virus from Africa in 2011 and the threat of rift valley fever moving into Europe.

"Climate change and activity such as the creation of wetlands to offset impacts may increase the presence of vectors such as ticks, mosquitoes and fleas, increasing the threat of transmissible diseases," Feller continued.

Effective medicines for the prevention and treatment of many vector-borne diseases are currently lacking. While vaccination is one of the most effective methods of tackling these diseases, investment in this area often falls short due to the huge costs and resources needed for research.

The process of bringing new veterinary medicines to market can cost up to €129 million, taking between five and 11 years to complete.

IFAH-Europe, which represents the animal health industry, is calling for incentives for companies to develop new medicines.

With Europe potentially set to see more diseases of animals and humans, innovative medicines and vaccine banks must be available for our armoury, IFAH has warned.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'